A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm.
Posted by rob on March 28, 2010 under Uncategorized | 
Comments are off for this article
 |
Related Articles |
A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm.
Leuk Res. 2010 Apr;34(4):e94-6
Authors: Véronèse L, Tchirkov A, Richard-Pebrel C, Ledoux-Pilon A, Fleury J, Chaleteix C, Goumy C, Gouas L, Berger MG, Vago P, Bay JO, Tournilhac O
PMID: 19833389 [PubMed - indexed for MEDLINE]